Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer.
about
Advances in pancreatic cancer research: moving towards early detectionNovel therapeutic targets for pancreatic cancerPancreatic Cancer Metabolism: Breaking It Down to Build It Back UpEpidemiology and Inherited Predisposition for Sporadic Pancreatic AdenocarcinomaWhat is good for the circulation also lessens cancer riskEnvironmental risk factors for pancreatic cancer: an update.Association of elevated risk of pancreatic cancer in diabetic patients: A systematic review and meta-analysisA novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical recordParity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies.Exercise-induced biochemical changes and their potential influence on cancer: a scientific reviewDiabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium.Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.Diabetes, pancreatic cancer, and metformin therapy.Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A.Prediagnostic body mass index and pancreatic cancer survival.Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan.Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysisMetformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control studyRelationship between HbA1c and cancer in people with or without diabetes: a systematic review.Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts.Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies.New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer.Rs488087 single nucleotide polymorphism as predictive risk factor for pancreatic cancersObesity and Cancer: An Angiogenic and Inflammatory Link.Premorbid Obesity and Mortality in Patients With Pancreatic Cancer: A Systematic Review and Meta-analysis.p21-Activated protein kinases and their emerging roles in glucose homeostasis.Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma.Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?TMEM45B promotes proliferation, invasion and migration and inhibits apoptosis in pancreatic cancer cells.Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective.Management of Cancer in the Older Age Person: An Approach to Complex Medical Decisions.Obesity-associated digestive cancers: A review of mechanisms and interventions.Survival analysis of veteran patients with pancreatic cancer.Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms.Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma.Facilitatory effect of insulin treatment on hepatocellular carcinoma development in diabetesCritical role for arginase 2 in obesity-associated pancreatic cancer.SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cellsA framework to understand diet, physical activity, body weight, and cancer risk.
P2860
Q24563998-672ACBD4-6F3C-4BD5-845E-10A45D6E7B06Q24564267-919944A1-7C03-44D5-9C5C-D66695007CE0Q26780372-8C0887EE-91F4-451D-B5D0-BE3A40354EFCQ26801418-BEE2E2D2-E12A-4481-9389-666EDF5E00C8Q26859261-95F73CD8-B25F-4A67-9879-DC64973D0771Q30248417-B02BD18A-3BDA-4448-9DFA-B10EF1F8D995Q33598407-12A742C7-03D2-4FF1-8E02-1BCCACA179E5Q33617565-E06872F9-857A-49ED-8F66-941E0D0ED7A4Q33766884-D08B90EB-4EF7-4B1D-9999-60A1D00F0451Q33785535-9B807E71-D0EE-4141-82EC-04D2C4ECEE45Q34250010-7D2CB0F3-AC33-458B-9D81-D47B6033CCF9Q34315320-0AA08C2D-437B-4A2C-84B9-035DEF27D280Q34471173-A633F7F9-0867-49FC-80CB-31997A491FC4Q34586212-8B6BC515-3484-420D-B342-F6E5C62BE858Q34656804-41B5393D-A134-42BD-92E7-68E08B966663Q34696720-7FDF5C05-7B81-47D9-84A4-8AAC70618799Q34803905-BF928422-D922-4301-BB46-27DE9B1FC5C5Q34899291-4B840297-C342-4207-8C4C-FBFAE9560FEDQ35844397-6DDE5616-FFF0-4783-AD8B-753CA76F32CFQ35896957-F804BC59-2E30-42B3-88B2-B384CEB1231BQ36207909-B01098FE-1655-4BCB-9186-31229EC81024Q36443863-A6B4683D-5468-4188-8D5C-9D114A7BCFC2Q36545489-51EE47B7-7D98-42AC-895D-94F5186FDCE5Q36759129-34D80D9D-0C70-439A-8029-8255849F6460Q37033546-56FDBA5A-4AD3-42B5-A17F-6B0D1BBBA690Q38173847-37524EB2-B54D-4432-B528-9EC90637F236Q38540380-91C78DDA-44C1-4FFD-8748-70C3F2A4E108Q38769343-BFCF594F-E4FD-4800-B331-2CCB4C9EBC00Q38775892-1448EE6B-A3EA-4B38-9758-0DD97300ED03Q38784706-761CBBCF-7030-4DB4-9604-AF8172F1C86BQ39026672-16E92B50-6733-4DD2-B47F-3DFB962AD65AQ39144746-576DA710-7CC9-4231-B3E6-B62428163C5AQ39205170-9CD24FD8-D83F-48B5-955C-3D51A118D134Q39729003-FCAF6F60-930C-4C51-8DEC-3FF42D48B148Q40515239-BD011CC6-2997-496B-A31F-9987AB1C5B8CQ40610844-DCE41E15-7147-4CF6-9919-33C0858B1EC2Q41109623-EDED10CA-8EAF-49AE-81E2-5CFB69671A7BQ41388458-4114AA7C-947D-4F62-B665-02C263D44799Q41959768-207C4CF1-6353-4D90-BB9D-5B11B9E6483CQ47177087-A018A65F-E868-4A75-BF8B-C98D4E4D2C62
P2860
Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hyperglycemia, insulin resista ...... and risk of pancreatic cancer.
@en
Hyperglycemia, insulin resista ...... and risk of pancreatic cancer.
@nl
type
label
Hyperglycemia, insulin resista ...... and risk of pancreatic cancer.
@en
Hyperglycemia, insulin resista ...... and risk of pancreatic cancer.
@nl
prefLabel
Hyperglycemia, insulin resista ...... and risk of pancreatic cancer.
@en
Hyperglycemia, insulin resista ...... and risk of pancreatic cancer.
@nl
P2093
P2860
P50
P356
P1476
Hyperglycemia, insulin resista ...... and risk of pancreatic cancer
@en
P2093
Anne McTiernan
Barbara B Cochrane
Brian M Wolpin
Howard D Sesso
JoAnn E Manson
John Michael Gaziano
Kaori Sato
Lawrence S Phillips
P2860
P304
P356
10.1093/JNCI/DJT123
P407
P577
2013-07-11T00:00:00Z